Sept. 19, 2014 SIGN IN | REGISTER
Vote Now: Where Should Roll Call Travel for the Midterm Elections?

Moniz Unveiled

CQ Roll Call’s Geof Koss sat down with Energy Secretary Ernest J. Moniz earlier this summer to discuss his relationship with Congress, as we mentioned last week. The whole story is now available outside the paywall.

Wireless Group Asks Lawmakers for Support on Net Neutrality Stance

The group representing wireless carriers is looking to Congress for help in trying to convince the Federal Communications Commission to continue treating mobile broadband differently from fixed broadband in its net neutrality rules, which has meant fewer requirements for mobile.

Scottish Independence: North Korean Annihilation of England Possibly Pending

Taller Towers for Better Wind

The Energy Department announced Thursday it would provide $2 million to support developing taller wind turbine towers that it says would cut generating costs.

Nelson Sees Potential Risk From Defective Chinese Cars

Just as some members of Congress are concerned about competition from state-supported Persian Gulf airlines and from Chinese airplane manufacturers, there may be a new potential threat in ground transportation, Sen. Bill Nelson, D-Fla., said this week.

Missile Defense Test Was No "Softball Shot," Says Boeing

That missile defense test from June, the first successful one in five years? It wasn’t “some softball shot,” as critics allege, according to Boeing officials managing the Ground-Based Midcourse Defense program. And in so far as it was “scripted,” they said, it was only because fully simulating a nuclear missile attack isn’t easy.

Friday Hearing Focuses on Antibiotic Resistance

One of the last events in Congress prior to lawmakers leaving for an election period recess break is a Friday morning House Energy and Commerce subcommittee meeting on the impact of the widespread use of antibiotics, featuring testimony from FDA drug development chief Janet Woodcock. The liberal use of antibiotics in humans reportedly is causing bacteria to develop resistance to current antibiotic drugs and the House panel will mull efforts to spur development of new drugs. Meanwhile, the White House this afternoon will announce new executive actions to combat antibiotic-resistant bacteria.

Repairing a Frayed Connection

Federal energy regulators trying to implement the Obama administration’s ambitious energy and climate agenda have found plenty of hostility in Washington during the past few years.

Conservation Group to Spend Record $25 Million on Midterms

The League of Conservation Voters will spend a record $25 million this cycle, organizers announced Thursday, five times what the environmental group spent on the 2010 midterms.

Allies Home to Fast-Growing Rivals for U.S. Air Carriers

Some United States allies in its struggle against the Islamic State are home to fast-growing airlines such as Etihad and Emirates competing with U.S. carriers. And that worries U.S. airlines.

Head of U.S. Copyright Office Will Tell Lawmakers Office is Understaffed

The U.S. Copyright Office is understaffed and could face additional strains in the future, according testimony by the head of the U.S. Copyright Office.

McDonnell Appeal Begs Question: What Is Corruption?

As Bob McDonnell’s lawyers gear up to appeal the former Virginia Governor’s conviction on 11 counts of bribery, conspiracy and extortion, federal prosecutors, legal experts and elected officials around the country are all watching closely.

Moniz Gives Shout-out to 3D Printed Car

Energy Secretary Ernest J. Moniz lauded efforts to produce a crowd-sourced electric car, the structure of which was printed in 44 hours at the International Manufacturing Technology Show last week.

FDA Panels Examine Testosterone Treatment

Food and Drug Administration panels this week are mulling the impact of the expanded use of testosterone medicine. The New York Times reported Wednesday that a drug advisory panel voted overwhelmingly to curb the prescribing of testosterone to middle-aged and elderly men for unproven uses such as low energy and low libido. Today, the FDA panels weigh whether the agency should approve an easier to use capsule version of the hormone. Clarus Therapeutics aims to get approval of the capsule for use in a market that now features gels, patches, injections and a gum treatment. But the advisers at the first day of a two-day meeting in Hyattsville, Md., expressed concern about possible side effects associated with testosterone, linked by some studies to a higher risk of stroke and heart attack. It now is only approved by the agency for men with low or no testosterone stemming from specific medical conditions.

House Unanimously Votes To Cut TSA Security Fees

Travel industry leaders are applauding a unanimous House vote Wednesday to roll back Transportation Security Administration fees.

More Policy News




Want Roll Call on your doorstep?